Can Sitagliptin prevent the decline of insulin sensitivity in type 2 diabetes, and how does it compare to other therapies in preserving metabolic health?
Sunil JoshiExplorer
Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
Sitagliptin primarily enhances insulin secretion rather than preventing insulin sensitivity decline, differing from therapies like metformin which improve insulin sensitivity.